ImmunoPrecise Antibodies Overview

ImmunoPrecise Antibodies Gross Profit

Gross Profit analysis for IPA.

Quarterly Gross Profit

$2.42M

↓ 26.44% YoY

As of Jan 31, 2026

Annual Gross Profit (TTM)

$11.10M

↓ 8.99% YoY

Trailing 12 months ending Jan 31, 2026

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin